期刊文献+

EPO对慢性缺氧心肌细胞线粒体生物合成的影响 被引量:4

Effect of erythropoietin on mitochondrial biogenesis in cardiomyocytes during chronic hypoxia in vitro
下载PDF
导出
摘要 目的观察促红细胞生成素(erythropoietin,EPO)在慢性缺氧条件下对心肌线粒体生物合成的影响及其可能的机制。方法将H9c2心肌细胞株置入缺氧培养箱7 d(94%N2,5%CO2,1%O2),建立H9c2心肌细胞株慢性缺氧模型;采用5、10、20 U/mL不同浓度的rhEPO(recombinant human erythropoietin;重组人促红细胞生成素)干预处理后,用荧光探针标记线粒体,观察线粒体数目的变化;RT-PCR技术检测线粒体DNA的相对拷贝数变化;Western blot技术检测Akt、eNOS及其磷酸化蛋白水平的变化。结果 rhEPO干预7 d后线粒体数目及拷贝数增加(P<0.05);Akt、eNOS蛋白磷酸化水平增强(P<0.05),Akt、eNOS总蛋白无明显变化(P>0.05)。结论 EPO增强了慢性缺氧心肌细胞的线粒体生物合成,Akt、eNOS可能是EPO增强线粒体生物合成的重要信号通路。 Objective To determine the effect of erythropoietin (EPO) on the mitochondrial bio- genesis in rat cardiomyocytes under the condition of chronic hypoxia. Methods Rat cardiomyocyte-derived H9c2 cells were deprived of oxygen for 7 d to establish the chronic hypoxia model (94% N2, 5% CO2and 1% 02 ). Then the obtained H9c2 cells were treated by recombinant human EPO (rhEPO, 5, 10 and 20 U/ml) for 3 or 7 d. Fluorescent probe was used to mark mitochondria in the cells for the amount of mitoehondria. The pro- tein levels of Akt, phospho-Akt ( serine473 ), endothelial nitric oxide synthase ( eNOS), and phospho-eNOS (serine1177) were determined with Western blotting. RT-PCR was used to detect the relative copy number of mitoehondrial DNA. Results rhEPO treatment for 7 d resulted in a significant increase in the amount and copy number of mitochondria ( P 〈 0. 05 ). The phosphorylation levels of Akt and eNOS were also enhanced, but those of akt and eNOS had no change ( P 〉 0. 05 ). Conclusion EPO improves mitochondrial biogenesis in the cardiomyocytes exposure to chronic hypoxia, probably through Akt and eNOS signal transduction.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2013年第12期1192-1196,共5页 Journal of Third Military Medical University
基金 国家自然科学基金青年科学基金(81100120)~~
关键词 促红细胞生成素 慢性缺氧 线粒体生物合成 蛋白激酶B(Akt) 内皮型一氧化氮合酶(eNOS) erythropoietin chronic hypoxia mitochondrial biogenesis Akt endothelial nitric oxidesynthase
  • 相关文献

参考文献16

  • 1Mao W, Iwai C, Liu J, et al. Darbepoetin alfa exerts a cardioprotective ef/ct in autoimmune cardiomyopathy via reduction of ER stress and ac- tivation of the PI3 K/Akt and STAT3 pathways[ J]. J Mol Cell Cardiol, 2008, 45 (2) : 250 - 260.
  • 2] Lombardero M, Kovacs K, Scheithauer B W. Erythropoietin: a hormone with muhlple functions [J. Pathobiology, 201 I, 78( 1 ) : 41 -53.
  • 3Steelman L S, Chappell W H, Abrams S L, et al. Roles of the R'af/ MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging [ J ]. Aging (Albany NY), 2011, 3(3) : 192-222.
  • 4Liang C, Ren Y, Tan H, et al. Rosiglitazone via upregulation of Akt/ eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products [ J ]. Br J Pharmacol, 2009, 158(8): 1865-1873.
  • 5Nisoli E, Clementi E, Moncada S, et al. Mitochondrial biogenesis as a cellular signaling franwork [J]. Bichem Pharmacol, 2004, 67(1): 1 -15.
  • 6E1-Hasnaoui-Saadani R, Marchant D, Pichon A, et al. Epo deficiencyalters cardiac adaptation to chronic hypoxia[ J]. Respir Physiol Neuro- biol, 2013, 186(2) : 146 - 154.
  • 7Sasaki R, Masuda S, Nagao M. Erythropoietin: multiple physiological functions and regulation of biosynthesis [ J ]. Biosci Biotechnol Bio- chem, 2000, 64(9): 1775-1793.
  • 8Maiese K, Li F, Chong Z Z. New avenues of exploration for erythropoi- etin[J]. JAMA, 2005, 293(1): 90-95.
  • 9Hewitson K S, McNeill L A, Schofield C J. Modulating the hypoxia-in- ducible factor signaling pathway: applications from cardiovascular dis- ease to cancer[J]. Curt Pharm Des, 2004, 10(8) : 821 -833.
  • 10Anagnostou A, Lee E S, Kessimian N, et al. Erythropoietin has a mi- togenic and positive chemotactic effect on endothelial cells [ J ]. Proc Natl Acad Sci U S A, 1990, 87(15) : 5978 -5982.

同被引文献55

  • 1邱祥聘.四川畜禽品种资源志[M].成都:四川科技出版社,1987.
  • 2王砚青,江时森.促红细胞生成素对心血管保护作用的研究进展[J].医学研究生学报,2007,20(10):1079-1083. 被引量:8
  • 3Hewitson KS, McNeill LA, Schofield CJ. Modulating tt~c hypoxia-inducihle factor signalling pathway: applications from cardiovascular disease to cancer [_J 1. Curr Pharm Des,2004,10(8) :821-833.
  • 4Nisoli E, Clementi E, Moncada S, et al. Mitochondrial bio genesis as a celluar signaling framework [J]. Biochem Pharmacol,2004,(37(1) :1 15.
  • 5Trinei M, Berniakovich I. Ppelicci PC, el al. Mimchondrial DNA copy number is regulated by cellular proliferation:a role for Ras and p66 (She)[J]. Biochim Biophys Acta, 2006,1757 (5/6) : 624-630.
  • 6Hoffman JI, Kaplan S. The incidence of congenital heart disease[J]. J Am Coil Cardiol,2002,39(12) :1890 1900.
  • 7Fu P, Arcasoy MO. Erythropoietin protects cardiac myo cytes against anthracycline-induced apoptosis~J2. Biochem Bioph Res (;o,2007,354(2):372 378.
  • 8Mao W,Iwai C,Liu J,et al. Darbepoetinalfa exerts a car- dioproteetive effect in autoimmune cardiomyopathy via re- duction of ER stress and activation of PI3K/Akt and STAT3 pathways[J1. J Mol Cell Cardiol,2008,45(2) 250-260.
  • 9Yamada Y, Kobayashi 'H, Iwasa M, et al. Postinfarct ac tive cardiac-targeted delivery of erythropoietin by lipo- somes with sialyl Lewis X repairs infareted myocardium in rabbits[J]. Am J Physiol Heart C, 201,3,304 (8) : Hl124- 1133.
  • 10Hasnaoui-Saadani RE, Marchant D, Pichon A, et al Epo deficiency alters cardiac adaptation to chronic hypoxia [J]. Respir Physiol Neurobiol,2013,186(2).:146-154.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部